Search

Your search keyword '"Svegliati-Baroni, G."' showing total 527 results

Search Constraints

Start Over You searched for: Author "Svegliati-Baroni, G." Remove constraint Author: "Svegliati-Baroni, G."
527 results on '"Svegliati-Baroni, G."'

Search Results

1. OC.05.2: FIRST AND FURTHER LIVER DECOMPENSATION IN PATIENTS WITH METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE: WHAT CLINICAL IMPACT?

2. Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary “Real Life” Experience

3. A global research priority agenda to advance public health responses to fatty liver disease

4. The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients

5. Outcomes of Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced hepatocellular carcinoma in the era of immunotherapy: A real-life comparison with best supportive care

6. Predictors of extrahepatic progression in patients with hepatocellular carcinoma receiving transarterial chemoembolization

7. Global multi-stakeholder endorsement of the MAFLD definition

8. Nationwide survey of liver transplantation for Primary Sclerosing Cholangitis in Italy

9. Preoperative predictors of recurrence beyond Milan criteria in hepatocellular carcinoma patients treated with frontline liver resection

10. Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced nonalcoholic fatty liver disease

12. Lack of substantial improvements in the landscape of alcohol-related hepatocellular carcinoma in the last 15 years: The need to improve cancer prevention and surveillance

13. A multi-society Delphi consensus statement on new fatty liver disease nomenclature

14. Corrigendum to 'Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)' Nutrition, Metabolism and Cardiovascular diseases volume 32 issue 1 (2022) 1-16

15. Corrigendum to 'Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)' [Dig Liver Dis 54 (2022) 170-182]

16. The impact of first and further decompensation in patients with metabolic-dysfunction associated compensated advanced chronic liver disease.

17. Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications

18. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

19. Pattern of macrovascular invasion in hepatocellular carcinoma

21. T.08.3 CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND HEPATOCELLULAR CARCINOMA

22. COVID-19 in an international European liver transplant recipient cohort

23. The Apparent Asymmetrical Relationship Between Small Bowel Bacterial Overgrowth, Endotoxemia, and Liver Steatosis and Fibrosis in Cirrhotic and Non-Cirrhotic Patients: A Single-Center Pilot Study

24. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

25. Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

26. Long-term albumin administration eases the management of hyponatremia in outpatients with decompensated cirrhosis: data from the ANSWER Trial

27. SARS-CoV-2 infection in liver transplantation is associated with favorable outcomes: an Italian transplant registry study

28. Digestive diseases. 2022-2025 edition

30. Hepatic venous pressure gradient (HVPG)-3P score as predictor tool of endoscopic signs of portal hypertension and liver-related events in patients with advanced chronic liver disease.

31. COVID-19 in an international European liver transplant recipient cohort

35. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

36. The pathophysiology of gut-liver connection

37. Pattern of macrovascular invasion in hepatocellular carcinoma

38. The changing scenario of hepatocellular carcinoma in Italy: an update

39. Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter

40. Identification of clinical phenotypes and related survival in patients with large hccs

41. Monofocal hepatocellular carcinoma: How much does size matter?

42. Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients

43. Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice

44. Pattern of macrovascular invasion in patients with hepatocellular carcinoma influences treatment and outcome

45. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

49. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial

Catalog

Books, media, physical & digital resources